All Deals
November 7, 2025 - Deals
Metropolis Technologies Closes $500 Million Series D Led By LionTree With $1.6 Billion Capitalization
Metropolis Technologies, Inc., a Los Angeles–based applied AI company, closed a $1.6 billion capitalization that included a $1.1 billion Term Loan B arranged by JP Morgan Chase Bank, N.A., and a $500 million Series D led by a fund managed by LionTree, with participation from BDT & MSD Partners’ affiliated credit funds, DFJ, Eldridge Industries, Slow Ventures, SoftBank Vision Fund 2, Tekne Capital, and Vista. Led by CEO and co-founder Alex Israel, the company plans to expand into new verticals and markets, scaling its AI platform into retail and hospitality. Metropolis’ computer vision–powered platform enables checkout-free payments and personalized experiences, and following its take-private acquisition of SP+, the company now operates the largest parking network in the U.S., spanning 4,200+ locations in 40 countries.
FOUNDER: Alex Israel
INVESTORS: LionTree, BDT & MSD Partners, DFJ, Eldridge Industries, Slow Ventures, SoftBank Vision Fund 2, Tekne Capital & Vista
ROUND: Series D
AMOUNT: $500,000,000
CAPITALIZATION: $1,600,000,000
HQ: #LosAngeles #California
#VentureCapital #MetropolisTechnologiesInc #LionTree #BDTandMSDPartners #DFJ #EldridgeIndustries #SlowVentures #SoftBankVisionFund2 #TekneCapital #Vista #TradedVC
More Deals
View All
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC